Monoclonal Antibodies in Multiple Sclerosis: Present and Future

Biomedicines - Switzerland
doi 10.3390/biomedicines7010020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Comorbidity in Multiple Sclerosis: Past, Present and Future

Clinical and Investigative Medicine
Medicine
2019English

Human Monoclonal Antibodies Reactive to Oligodendrocytes Promote Remyelination in a Model of Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Rickettsial and Viral Antibodies in Multiple Sclerosis

BMJ
1962English

The Past, Present, and Future of Monoclonal Antibodies to IL-5 and Eosinophilic Asthma: A Review

Journal of Asthma and Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2015English

Virus Specific Antibodies in Multiple Sclerosis.

BMJ
1972English

KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis

Frontiers in Neurology
Neurology
2014English

Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis

JAMA - Journal of the American Medical Association
Medicine
2001English

Clinico-Radiological Dissociation in Multiple Sclerosis: Future Prospects

World Journal of Neuroscience
2013English

G1m1 Predominance of Intrathecal Virus-Specific Antibodies in Multiple Sclerosis

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy